Cipla Pharma And Life Sciences Limited - Due diligence report

A 360° intelligence report on Cipla: trust score, financial health, credit view, compliance, directors, growth and distress signals - genera…

2008-08-20 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
CP Cipla Pharma And Life Sciences Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Cipla — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Cipla is assessed as Moderate with a Trust Score of 72/100. Cipla is an active public limited indian non-government company incorporated in 2008, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 31 Jul 2026 from the latest processed filings. Cipla Pharma And Life Sciences Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
83/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 83/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: Deshpande Jain & Associates on 2015-04-01.
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
ANISHA NARESH UDESHI 01234567 Director 01/04/2018 6 yrs Approved
Sunil Jvalaprsad Gupta 01234567 Director 01/04/2018 6 yrs Approved
Akshaya Rajendra Kolvankar 01234567 Director 01/04/2018 6 yrs Approved
JINESH CHAUHAN 01234567 Director 01/04/2018 6 yrs Approved
RAJENDRA KUMAR CHOPRA 01234567 Director 01/04/2018 6 yrs Approved
RAJU SUNIL MISTRY 01234567 Director 01/04/2018 6 yrs Approved
Gargi Sadanand Sahasrabudhe 01234567 Director 01/04/2018 6 yrs Approved
Sarvesh Ketan Padalkar 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2018)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Cipla Limited
Subsidiaries
-
Group entities
-
Capital events
20 allotment(s) · 7 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Cipla Limited Holding Company 74.00%

Key managerial personnel: Sunil Jvalaprsad Gupta (Managing Director) · JINESH CHAUHAN (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 17+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment69/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view48/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
RAJU SUNIL MISTRY
26 Jun 2025
Director appointed
Gargi Sadanand Sahasrabudhe (Company Secretary)
01 Jun 2025
Director appointed
RAJU SUNIL MISTRY (Additional Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
25 Jun 2024
Director appointed
Sarvesh Ketan Padalkar (Cfo)
11 Mar 2024
Director ceased
Sunil Jvalaprsad Gupta
07 Mar 2024
Director ceased
ACHIN GUPTA
02 Feb 2024
Director appointed
Sunil Jvalaprsad Gupta (Managing Director)
01 Apr 2023
Director appointed
JINESH CHAUHAN (Whole-time director)
Director ceased
JINESH CHAUHAN
31 Mar 2022
Share transfer (FY 2022)
1.00000000 shares to Ramanath Suryanarayana Mosale
Share transfer (FY 2022)
1.00000000 shares to Rahul Verma
Share transfer (FY 2022)
1.00000000 shares to Anisha Udeshi
Share transfer (FY 2022)
1.00000000 shares to Girish Zamwar
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 20 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Geospoc U74900PN2015PTC155597 Pune, Maharashtra, India
Tectura U72300DL1999PTC100368 Delhi, Delhi, India
Tech Ecs Limited U72300TG2015PLC097869 Hyderabad, Telangana, India
Ag Furnace Improvements Private Limited U74140DL2004PTC126065 New Delhi, Delhi, India
Umed Pharma Lab Private Limited U24232TG2012PTC081082 Hyderabad, Telangana, India
As Cooling Technologies India Private Limited U74999DL2018PTC331295 New Delhi, Delhi, India
Curejoy U74110KA2014FTC073935 Bangalore South, Karnataka, India
Monjin U74900PN2012PTC142995 Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Cipla before audits and certifications: compliance score 83/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Cipla: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Cipla - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Cipla pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Cipla - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Cipla an active company?

Cipla has MCA status “Active” with a compliance score of 83/100 (Low Risk).

Is Cipla financially healthy?

Cipla has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Cipla?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Cipla?

The ultimate holding entity is Cipla Limited. 8 active director(s) are on record.

Does Cipla have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Cipla up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 83/100 (Low Risk).

Is it risky to lend to Cipla?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.